2024-517939-53-00招募中1 期
Adoptive TIL therapy in combination with chemoimmunotherapy in advanced NSCLC patients
Leids Universitair Medisch Centrum (LUMC)1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2024年11月15日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 15
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
L.C. Steinbusch
Scientific
Leids Universitair Medisch Centrum (LUMC)
研究点 (1)
Loading locations...
相似试验
尚未招募
不适用
Adoptive TIL therapy in combination with chemoimmunotherapy in advanced NSCLC patients10029107non-small cell lung cancerNL-OMON53375eids Universitair Medisch Centrum15
尚未招募
2 期
A Phase 2 Randomized, Controlled Trial of QL1706 Plus Chemotherapy and Quad Shot for Driver Gene-negative Advanced Non-small Cell Lung Cancer.NCT07271602Union Hospital, Tongji Medical College, Huazhong University of Science and Technology104
招募中
2 期
The MAYA2 trialColorectal cancer2025-521941-25-00Odense University Hospital165
招募中
2 期
A phase 2, Multicenter Study of TILs Treatment in Advanced Tumors with Alterations in the SWI/SNF Complex: the TILTS Study2023-504632-17-00Fundacio Institut D Investigacio Biomedica De Bellvitge IDIBELL, Fundacio Institut D Investigacio Biomedica De Bellvitge IDIBELL11
进行中（未招募）
不适用
Adoptive Immunotherapy of chemotherapy refractory CMV infections using Streptamer-isolated T cells after allogeneic bone marrow or peripheral blood stem cell transplantation: a phase I/II trial - AIT-CMV-Stage-01-chronic persistent CMV infection after allogeneic bone marrow or peripheral blood stem cell transplantation, refractory to antiviral chemotherapyEUCTR2006-006146-34-DEStage Pharmaceuticals GmbH30